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Aim To investigate whether intra-personal variation in se-
rum uric acid concentration is influenced by genes that 
were described to be associated with serum uric acid lev-
els in cross-sectional studies.
Methods The study included 92 participants from the iso-
lated community of the Croatian island of Vis. For each par-
ticipant, two uric acid concentration measurements were 
available, one from 2002 and one from 2003. Changes in 
uric acid concentration were correlated with a set of 8 
genes known to affect it: PDZK1, GCKR, SLC2A9, ABCG2, 
LRRC16A, SLC17A3, SLC16A9, and SLC22A12.
Results Thirteen participants (14%) had uric acid concen-
tration change greater than 130 μmol/L. Greater variability 
of uric acid concentration was recorded in women (coef-
ficient of variation 49% vs 12% in men). Two single-nucle-
otide polymorphisms (SNP) belonging to SLC17A3 gene 
(rs9393672 and rs942379) yielded significant association 
with serum uric acid concentration changes in women. 
These two SNPs explained 0.2%-1.3% of variance for 2002 
or 2003 uric acid measurement and 1.1%-1.8% of variance 
for the average value of these two measurements.
Conclusions Repeated measurements offer a possibility 
to enrich the percent of explained variance and contribute 
to the understanding of the “missing heritability” concept. 
Although a number of genes have been shown to affect 
serum uric acid concentration, SLC17A3 seems to have a 
major role in determination of serum uric acid repeated 
measurements variation.
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Serum uric acid in humans is a quantitative trait that has late-
ly received a lot of research attention (1). This is primarily due 
to the current disagreement whether it is a disease risk or a 
protective factor (2-5). While older studies often refer to it as 
a cause of gout and associate it with other metabolic dis-
eases, some recent studies suggest that it might be among 
the most potent anti-oxidants in the human body (6,7). Fur-
thermore, substantial progress in our understanding of its 
metabolism and biology has recently been made, due to 
description of a number of genes that affect it (4). However, 
clinical importance of uric acid and the possibility to use it as 
a disease marker still remain a matter of dispute (5).
Genetic background of uric acid determination has most 
commonly been described in genome-wide association 
studies, which correlate a single uric acid measurement to 
a large number of genetic markers (8,9). Although this ap-
proach has yielded a number of interesting results, it relies 
on the key assumption that a single measurement of uric 
acid concentration is a good proxy for this trait. However, 
studies have reported that serum uric acid concentrations 
show substantial variation even within a single day (10) or 
during periods as long as years (11-15).
Theoretically, studies of phenotypic traits that are not very 
reproducible suffer from a lack of statistical power and con-
sequently have greater chances of producing false positive 
or false negative results. Furthermore, such underpowered 
studies may produce underestimated percentages of vari-
ance attributable to genetic factors in phenotypic trait de-
termination. This is often seen in genome-wide association 
studies that manage to explain no more than a few percents 
of variance for majority of human quantitative traits, despite 
the fact that they are sometimes based on more than a hun-
dred thousand samples (16,17). The difference between 
high heritability and low percent of explained variance of 
genetic factors was entitled the “missing heritability,” and 
it is currently one of the central issues in human genetics 
(16,18,19). Therefore, the aim of this study was to investigate 
the repeatability of serum uric acid concentration measure-
ments in an isolated island population, to examine whether 
there is a genetic background of serum uric acid concentra-
tion changes, and to investigate the possibility to use mul-
tiple phenotypic measurements in genetic epidemiology.
POPulaTIOn and MeThOds
study population
Data for the study were obtained from a larger genetic epi-
demiology program performed on some of the Croatian 
Adriatic islands (20-24). The study sample included partici-
pants from the island of Vis who took part in the pilot study 
in 2002 and were later recruited to a larger gene mapping 
effort (25-28). In both cases, a population-based approach 
was applied, which included first informing the local com-
munity and then sending out the postal invitations. Par-
ticipation was open for all individuals who would respond 
to it. Sampling frame comprised 200 participants in 2002 
and 1057 in 2003. Those who responded to both invita-
tions were included in this study.
The population of the island is an interesting isolate, due 
to genetic, geographical, and even partial linguistic isola-
tion (21,29). After almost a decade of detailed work in this 
population, a number of specific characteristics were de-
scribed in some population genetics features (29-35) and 
epidemiological, environmental, and behavioral disease 
risk factors (36-38), making the island a large biomedical 
research resource (39).
All participants were given detailed study information 
prior to the enrolment and gave signed consent to par-
ticipate in the study. The study was approved by the Eth-
ics Committee of the Medical School, University of Zagreb 
and the Multi-Centre Research Ethics Committee for Scot-
land. Further details on this program are available else-
where (21,29).
Measurements
Blood samples were taken from all participants, immedi-
ately frozen, and transported frozen to the laboratory that 
performed the measurement. Both uric acid measure-
ments, from 2002 and 2003, were performed in a single 
laboratory, which did not change quantification method-
ology during that period. Sequential analyses and labora-
tory quality controls check-ups were within the expected 
and certified ranges. Serum uric acid measurements were 
based on the uricase UV photometry, performed by Olym-
pus AU400 (Olympus Corp, Tokyo, Japan), according to the 
manufacturer’s instructions.
The initial analysis of uric acid concentrations was aimed 
toward understanding the pattern of annual variation. In 
order to provide estimates for this, we calculated coef-
ficient of variation, which was calculated for the entire 
sample and for sex-stratified sub-samples. Furthermore, 
we performed Bland-Altman agreement analysis (40), 
which uses graphical output to indicate the agreement 
between two measurements based on the com-
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parison of the difference and the means of two measure-
ments. This approach offers a substantial methodological 
advancement over the calculation of correlation coeffi-
cients between the two measurements (41).
Furthermore, all participants were classified into two 
groups according to the extent of serum uric acid con-
centration change. Participants with absolute value of dif-
ference between the two measurements higher than 130 
μmol/L (roughly a third of the upper laboratory range limit) 
were compared to those with difference between the two 
measurements lower than 130 μmol/L.
Besides uric acid, we used blood samples for DNA extrac-
tion. After extraction, all samples were genotyped using Il-
lumina HumanHap 300 panel, version 1, (Illumina Inc., San 
Diego, CA, USA), with 317 508 single-nucleotide polymor-
phisms (SNP). Among them, 16 SNPs belonging to 8 genes 
that were previously associated with uric acid (8,9), were se-
lected and used in the analysis. These included rs1797052 
and rs1298954 from PDZK1 gene, rs780094 from GCKR 
gene, rs13129697, rs4447863, rs13131257, rs6449213, 
rs1014290, and rs733175 from SLC2A9, rs2231142 from 
ABCG2, rs9358856 from LRRC16A, rs9393672 and rs942379 
from SLC17A3, rs2242206 from SLC16A9, and rs2078267 
and rs505802 from SLC22A12 gene. Further information 
on these SNPs and genes is provided elsewhere (9).
statistical analysis
Numerical data were presented as means and standard 
deviations, since the assumption of normality was satis-
fied, according to the Kolmogorov-Smirnov test. Categori-
cal data were presented as numbers and percentages. The 
data were analyzed using χ2 test or Fisher exact test; the 
latter was used when the expected values in more than 
20% of cells were less than 5. Numerical variables were an-
alyzed with t-test for dependent samples (comparison of 
two uric acid concentration measurements). Additionally, 
general linear modeling was employed to calculate the 
percent of variance that was explained by genetic mark-
ers. Selected single-nucleotide polymorphisms (SNP) were 
used as predictors, while uric acid concentration was used 
as an outcome variable. Three different values of uric acid 
were used: measurement from 2002, measurement from 
2003, and the average value of these two measurements. 
Linkage disequilibrium between genetic markers was cal-
culated using PLINK (42), but only for the selected two 
SNPs. Analysis was performed in R (43), except for Fisher 
exact test that was performed using Simple Interac-
tive Statistical Analysis (SISA) (44). Since 16 SNPs were in-
cluded in the analysis, a Bonferroni correction was applied. 
Calculation of the P value correction was based on 16 com-
parisons and the initial value of P < 0.05. The final outcome 
of the P value correction was that significance limit was set 
to P < 0.0031.
ResulTs
The study included 92 samples from 38 men and 53 wom-
en (Table 1). Average serum uric acid concentration was 
greater in 2003 than in 2002, with a largely different co-
efficient of variation in men and women (Table 1). When 
all measurements were ranked according to the greatest 
change between the two sampling periods, there were 
Table 1. basic characteristics of the study participants
Men
(n = 38)
Women
(n = 53) Total
Age (years); 
mean ± standard deviation
59.6 ± 12.3 59.3 ± 13.4 59.4 ± 12.9
Uric acid, 2002 mea-
surement (μmol/L); 
mean ± standard deviation
353.3 ± 55.0 259.0 ± 94.5 298.4 ± 92.7
Uric acid, 2003 mea-
surement (μmol/L); 
mean ± standard deviation
381.7 ± 88.7 268.9 ± 76.4 316.0 ± 98.7
Coefficient of variation 
between 2002 and 2003 
measurement; %
 11.5  49.3  39.9
Figure 1.
bland-altman chart for the uric acid concentration changes in men and 
women; dashed lines represent a cut-off value for uric acid serum con-
centration of 130 μmol/l. Grey trinagle – men; open circle – women.
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8 women and only 2 men in top 10 samples. The use of 
Bland-Altman agreement approach indicated that there 
were directional changes in uric acid concentrations in 
men, while it showed seemingly equal dispersal in women 
(Figure 1). This was further confirmed using the t-test for 
repeated samples, where the entire sample showed signif-
icant change between the 2002 and 2003 measurements 
(P < 0.001). This was due to the changes in men (P < 0.001) 
but not in women (P = 0.916).
The changes of serum uric acid concentration greater 
than 130 μmol/L were then correlated with a set of 16 
SNPs that were previously associated with the serum uric 
acid concentrations in cross-sectional studies. The analy-
sis yielded 2 SNPs that were significantly associated with 
these changes, both belonging to a single gene, SLC17A3 
(Table 2). The subsequent analysis suggested that these 2 
SNPs were in a strong linkage disequilibrium (r2 = 0.923). 
Despite overall small sample size, the total sample was ad-
ditionally stratified by sex in order to investigate possible 
sex-specific differences. This revealed that the changes of 
uric acid concentration were not associated with these 
2 SNPs (rs9393672 and rs942379) in men (P = 0.073 and 
P = 0.061, respectively; Fisher exact test), but were in wom-
en (P = 0.003 and P = 0.001, respectively).
Lastly, uric acid concentration was used as the target vari-
able in 3 general linear models aiming to estimate the 
percent of variance that was attributable to the genetic 
markers. Each of the 2 selected SNPs were entered in 
the model as predictors separately, with 3 outcome 
Table 2. The association of the uric acid changes higher and 
lower than 130 μmol/l with the set of 16 loci implicated in the 
uric acid metabolism
Gene and short uric acid changes
nucleotide poly-
morphism; n (%) Genotype
higher than 
130 μmol/l
lower than 
130 μmol/l P
PdZK1
rs1797052 AG 1 (14.3) 6 (85.7) 0.734*
GG 12 (14.5) 71 (85.5)
rs1298954 AA 1 (14.3) 6 (85.7) 0.999†
AG 6 (14.3) 36 (85.7)
GG 6 (14.6) 35 (85.4)
GCKR
rs780094 AA 1 (9.1) 10 (90.9) 0.059*
AG 7 (13) 47 (87)
GG 5 (20.8) 19 (79.2)
slC2a9
rs13129697 AA 6 (23.1) 20 (76.9) 0.024*
AC 6 (13) 40 (87)
CC 1 (5.6) 17 (94.4)
rs4447863 AA 1 (11.1) 8 (88.9) 0.191†
AG 8 (22.9) 27 (77.1)
GG 4 (8.7) 42 (91.3)
rs13131257 AA 0 (0) 9 (100) 0.385†
AG 6 (14.3) 36 (85.7)
GG 7 (17.9) 32 (82.1)
rs6449213 AA 8 (20.5) 31 (79.5) 0.269†
AG 5 (12.2) 36 (87.8)
GG 0 (0) 8 (100)
rs1014290 AA 7 (22.6) 24 (77.4) 0.015*
AG 6 (13) 40 (87)
GG 0 (0) 13 (100)
rs733175 AA 9 (23.1) 30 (76.9) 0.096†
AG 4 (9.5) 38 (90.5)
GG 0 (0) 9 (100)
abCG2
rs2231142 AC 1 (11.1) 8 (88.9) 0.616*
CC 12 (14.8) 69 (85.2)
lRRC16a
rs9358856 AA 1 (50) 1 (50) 0.062*
AG 3 (17.6) 14 (82.4)
GG 9 (12.7) 62 (87.3)
slC17a3
rs9393672 AA 5 (50) 5 (50) 0.003†
AC 5 (11.6) 38 (88.4)
CC 3 (8.1) 34 (91.9)
rs942379 AA 5 (62.5) 3 (37.5) <0.001†
AG 5 (11.9) 37 (88.1)
GG 3 (7.7) 36 (92.3)
slC16a9
rs2242206 AA 1 (20) 4 (80) 0.087*
AC 4 (14.8) 23 (85.2)
CC 8 (13.8) 50 (86.2)
slC22a12
rs2078267 AA 4 (21.1) 15 (78.9) 0.050*
AG 6 (13.3) 39 (86.7)
GG 3 (11.5) 23 (88.5)
rs505802 AA 6 (14.6) 35 (85.4) 0.062*
AG 7 (17.1) 34 (82.9)
GG 0 (0.0) 8 (100.0)
Total; n (%) – 13 (14.3) 78 (85.7) –
*Fisher exact test.
†χ2 test.
Table 2. Continued… The association of the uric acid changes 
higher and lower than 130 μmol/l with the set of 16 loci impli-
cated in the uric acid metabolism
Gene and short uric acid changes
nucleotide poly-
morphism; n (%) Genotype
higher than 
130 μmol/l
lower than 
130 μmol/l P
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variables – uric acid concentration measured in 2002, mea-
sured in 2003, and average value of these 2 measurements. 
The results indicated that the percent of variance for SNP 
rs9393672 was 0.2% for 2002 measurement, 0.7% for 2003 
measurement, and 1.1 for average uric acid concentration; 
rs942379 yielded a total of 0.7% of variance for 2002 mea-
surement, 1.3% for 2003 measurement, and 1.8% for the 
average uric acid concentration.
dIsCussIOn
This study suggests that gene SLC17A3 (solute carrier fam-
ily 17 [sodium phosphate] member 3, also known as NPT4 
- Na(+)/PI cotransporter 4) may have a strong effect on 
substantial changes of serum uric acid concentration in re-
peated measurements, while other proposed genes were 
not significantly associated with these changes. Further-
more, although women showed overall greater variability 
of serum uric acid concentration, this study suggests that 
the effects of SCL17A3 were present in women but not in 
men.
SLC17A3 belongs to the large family of solute carriers, in-
volved in the urinary urate reabsorption (4). However, its 
exact role in the urate metabolism remains to be investi-
gated (4). Currently, it seems that mutations in this gene 
that involve the existence of AA genotype have a strong ef-
fect on substantial changes of the uric acid concentration, 
and may even be involved in the variability of serum uric 
acid. A step forward in this line of research could be the 
sequential investigation of uric acid concentration in par-
ticipants with all 3 genotypes (AA, A/C, or CC for rs9393672 
and AA, A/G, and GG for rs942379), based on multiple uric 
acid concentration measures, which could provide addi-
tional information on the extent of variation. If such a study 
is performed on a sex-stratified sample, it could even shed 
more light on the sex-dependent determination of uric 
acid concentration, which was suggested in a number of 
previous studies (3,6,8,9,45).
Serum uric acid concentration seems to be a highly com-
plex trait, affected by a number of described genes and 
environmental factors (1,4,8,9,46). One of the very interest-
ing research areas investigates the relationship of the uric 
acid, gout, nephrolithiasis, and metabolic syndrome (4). 
This is even more interesting knowing that some of the 
genes associated with uric acid have been independent-
ly associated with gout (47), while the other have not 
shown any association with either of the metabolic or 
even cardiovascular diseases (48). These results sug-
gest that we lack the proper information on uric acid de-
termination, which is why some characteristics of isolated 
populations could be considered as an important research 
resource (49-51).
The use of average value of two or more phenotypic mea-
surement instead a single measurement seems to provide 
an interesting way of increasing the percent of SNP-attrib-
utable explained variance in quantitative trait analysis. The 
amount of variance in this study increased for over one half 
when only two uric acid measurements were averaged 
compared with any single measurement. This offers an ex-
citing possibility that a fair share of genome-wide associa-
tion studies, which were as a rule based on a single mea-
surement and yielded only a small percent of variance (52), 
could be substantially improved by the provision of an ad-
ditional phenotypic measurement. This could also contrib-
ute to the solving one of the key contemporary issues in 
genetic epidemiology, a problem of missing heritability, ie, 
the finding that genetic markers, such as SNPs, fail to ex-
plain a substantial amount of heritability for any given trait 
(16). The examples for missing heritability are numerous, 
including heritability of height which is close to 95%, while 
huge genetic mapping efforts managed to identify over 
40 variants which all together explain as much as 5% of to-
tal height variance (26,53-56), or type-2 diabetes where 18 
loci explain as much as 6% of total variance (16). The pos-
sible causes for this discrepancy include a number of rea-
sons, among which is also the possibility that phenotypic 
measurements are imprecise (19). If this is a true problem 
in genetic epidemiology, then we could expect to see a 
gradient of strength of association between genetic mark-
ers and traits that are highly repeatable and easy to mea-
sure (ie, height) toward less likely significant results in less 
repeatable and more variable traits (ie, serum measures, es-
pecially hormones). Since we do not often see such a gra-
dient, especially not in height genetics (55), it could be hy-
pothesized that this mechanism is not particularly strong 
or prevalent. Furthermore, such problems are likely to be 
overcome in meta-analytic studies, which serve as a potent 
mechanism for random variation removal or control, with 
substantial enrichment of significant results (9), compared 
with results from a single study (8). Nevertheless, the re-
sults presented here suggest that phenotyping inaccuracy 
may introduce certain amount of variance dissolution, and 
that the averaging of two measurements of the same trait 
may increase the percent of explained variance.
The limitations of this study include a rather small sample 
size, which may have caused the large coefficient of vari-
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ation. Due to this, one of next steps is to replicate these 
results in an independent population or populations. Fur-
thermore, the samples originated from an isolated popu-
lation with possibly unique genetic make-up and specific 
environmental determinants, making these results per-
haps less generalizable. Furthermore, certain levels of re-
latedness were expected among participants, which could 
have affected the results. The extent of variation recorded 
among women in this study was several orders of magni-
tude greater than that in a previously published one (11), 
which could also be regarded as a local population feature, 
acting in favor of detecting a gene associated with strong 
serum uric acid changes. Despite all these limitations, this 
study suggests that uric acid concentration changes in 
longitudinal measurements are under strong effect of the 
SLC17A3 gene. If similar results are obtained in other stud-
ies, it could be hypothesized that repeated phenotypic 
measurements may provide a substantial contribution to-
ward understanding of such a fundamental questions of 
modern genetic epidemiology as the missing heritability.
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